Related Experiment Video
Updated: Mar 30, 2026
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Vascular repair strategies in type 2 diabetes: novel insights
Kira Kuschnerus1, Ulf Landmesser1, Nicolle Kränkel1
1Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Medizinische Klinik für Kardiologie, Berlin, Germany.
Abstract:
Impaired functions of vascular cells are responsible for the majority of complications in patients with type 2 diabetes (T2D). Recently a better understanding of mechanisms contributing to development of vascular dysfunction and the role of systemic inflammatory activation and functional alterations of several secretory organs, of which adipose tissue has more recently been investigated, has been achieved. Notably, the progression of vascular disease within the context of T2D appears to be driven by a multitude of incremental signaling shifts. Hence, successful therapies need to target several mechanisms in parallel, and over a long time period. This review will summarize the latest molecular strategies and translational developments of cardiovascular therapy in patients with T2D.
Insights
Vascular cell dysfunction drives type 2 diabetes complications. New molecular strategies targeting multiple pathways are crucial for effective, long-term cardiovascular therapy in these patients.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Molecular Biology
Background:
- Vascular cell dysfunction is a primary cause of type 2 diabetes (T2D) complications.
- Systemic inflammation and altered function of secretory organs, like adipose tissue, contribute to vascular dysfunction in T2D.
- Vascular disease progression in T2D involves numerous incremental signaling shifts.
Purpose of the Study:
- To review the latest molecular strategies for cardiovascular therapy in T2D.
- To discuss translational developments in treating T2D-related vascular complications.
Main Methods:
- Literature review of recent molecular strategies.
- Analysis of translational research in cardiovascular therapy for T2D.
Main Results:
- Understanding of mechanisms underlying vascular dysfunction in T2D has improved.
- The role of systemic inflammation and adipose tissue dysfunction is increasingly recognized.
- Multifaceted signaling shifts drive T2D vascular disease progression.
Conclusions:
- Effective cardiovascular therapies for T2D require parallel targeting of multiple mechanisms.
- Long-term therapeutic strategies are essential for managing T2D vascular complications.
